Drug Wars : How Big Pharma Raises Prices and Keeps Generics off the Market
By: Feldman, Robin | Frondorf, Evan.
Publisher: Cambridge University Press 2017Description: 160, pp.ISBN: 9781107168480.Subject(s): Pharmaceutical industry | Drugs--Prices | Drugs--Law and legislation | Generic drugs | Pharmaceutical policy | United StatesDDC classification: 338.476151 Summary: While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.| Item type | Current location | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
Books
|
NASSDOC Library | 338.476151 FEL-D (Browse shelf) | Available | 51501 |
Browsing NASSDOC Library Shelves Close shelf browser
|
|
|
|
|
|
|
||
| 338.476 BAR Making Cars in the New India | 338.4760941 WES; Western sunrise: the genesis and growth of Britain's major high tech corridor | 338.4760954 KRI-H High-Tech Internet Start-Ups in India | 338.476151 FEL-D Drug Wars | 338.476151 POL; Politics of the pharmaceutical industry and access to medicines: world pharmacy and India | 338.4761510954 ACC- Access to medicines in India / | 338.4761510954 JOS-P Pharmaceutical Industry and Public Policy in Post-Reform India |
While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.
There are no comments for this item.